Jingcheng Bi Selected Research

Critical Illness (Critically Ill)

3/2015

Use of n-3 PUFAs can decrease the mortality in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jingcheng Bi Research Topics

Disease

2	Inflammation (Inflammations) 01/2021 - 02/2016
1	Chemotherapy-Related Cognitive Impairment 10/2022
1	Breast Neoplasms (Breast Cancer) 10/2022
1	Cognitive Dysfunction 10/2022
1	Ischemia 09/2016
1	Hemorrhagic Shock 09/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016
1	Endotoxemia 02/2016
1	Weight Gain 02/2016
1	Obesity 02/2016
1	Atrophy 01/2016
1	Cerebellar Neoplasms 10/2015
1	Brain Neoplasms (Brain Tumor) 10/2015
1	Superior Mesenteric Artery Syndrome 10/2015
1	Vomiting 10/2015
1	Weight Loss (Weight Reduction) 10/2015
1	Infections 08/2015
1	Critical Illness (Critically Ill) 03/2015
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 03/2015

Drug/Important Bio-Agent (IBA)

2	Glucagon (Glukagon)FDA Link 01/2021 - 01/2016
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 09/2016 - 03/2015
1	ORALIT (ORS)IBA 03/2016
1	PectinsIBA 02/2016
1	CholesterolIBA 02/2016
1	AntioxidantsIBA 01/2016

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 10/2022
1	Catheters 01/2021
1	Resuscitation 09/2016
1	Total Parenteral Nutrition 01/2016
1	Cranial Irradiation 10/2015
1	Radiotherapy 10/2015
1	Parenteral Nutrition 08/2015
1	Enteral Nutrition (Feeding, Tube) 08/2015